These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8765697)

  • 1. In vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides.
    Vial-Bernasconi AC; Buri P; Doelker E; Beyssac E; Duchaix G; Aiache JM
    Pharm Acta Helv; 1995 Dec; 70(4):307-13. PubMed ID: 8765697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet.
    Garikipati V; Toops DS; Fang Q
    Curr Med Res Opin; 2008 Jul; 24(7):1869-76. PubMed ID: 18593524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin.
    Manvelian G; Daniels S; Altman R
    Postgrad Med; 2012 Jul; 124(4):197-205. PubMed ID: 22913908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
    Choi Y; Min KA; Kim CK
    Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative bioavailability of three ibuprofen formulations in healthy human volunteers.
    Mendes GD; Mendes FD; Domingues CC; Oliveira RA; da Silva MA; Chen LS; Ilha JO; Fernandes CE; Nucci GD
    Int J Clin Pharmacol Ther; 2008 Jun; 46(6):309-18. PubMed ID: 18541128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability.
    Rowe JS; Carless JE
    J Pharm Pharmacol; 1981 Sep; 33(9):561-4. PubMed ID: 6117632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of indomethacin from two multiple-units controlled-release formulations.
    Bechgaard H; Brodie RR; Chasseaud LF; Houmøller P; Hunter JO; Siklos P; Taylor T
    Eur J Clin Pharmacol; 1982; 21(6):511-5. PubMed ID: 7075656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
    Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations.
    Avramoff A; Laor A; Kitzes-Cohen R; Farin D; Domb AJ
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):126-32. PubMed ID: 17323793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability studies on fast release formulations of indomethacin.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2002; 141(3):176-80. PubMed ID: 12197414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
    Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
    Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
    Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
    Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of two minocycline capsule formulations in healthy volunteers.
    Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID
    Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of polymorphism on the manufacturability and in vitro dissolution of sulindac-containing hard gelatin capsules.
    Guadalupe Sánchez-González E; Yépez-Mulia L; Jesús Hernández-Abad V; Jung Cook H
    Pharm Dev Technol; 2015 May; 20(3):306-13. PubMed ID: 24417644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.